European Medicines Agency investigating Pandemrix

by Tina Redlup on September 2, 2010

185px-h1n1_navbox

Swine flu

Officials with the European Medicines Agency are looking into the safety of the swine flu vaccine Pandemrix after reports surfaced that the treatment may be linked to a rare sleep disorder.

Current H1N1 vaccine protects against 1918 strain

by Ted Purlain on June 18, 2010

H1n1

H1N1

In a finding that could reduce concern over a potential release of the strain, a team of researchers in the U.S. reported this week that the current H1N1 vaccine protects mice and possibly humans against the 1918 pandemic virus.

Pandemic flu on the rise in several nations

by Ted Purlain on June 15, 2010

H1n1

H1N1

Pandemic flu activity is picking up in parts of India and Colombia, and New Zealand is seeing a rise in flu-like illnesses in young children, CIDRAP News has reported.

Flu summit held in West Virginia

by Ted Purlain on June 12, 2010

Flu_vaccine

Health officials in West Virginia are hoping to encourage influenza immunizations by holding the state's first annual flu summit.

Tamiflu shows effectiveness in infants

by Ted Purlain on June 9, 2010

Tamiflu

German researchers have announced that Tamiflu given to infants hospitalized with influenza had similar benefits to those in older children, though mild gastrointestinal symptoms were a common side effect.

AVI BioPharma gets up to $18M to study swine flu

by Ashton Daigle on June 9, 2010

Swine-flu

Swine flu

Officials with AVI BioPharma Inc., recently announced that they have entered into an $18 million deal with the U.S. Defense Threat Reduction Agency, according to a Portland Business Journal news report.

Canadian swine flu vaccination programs failing

by Tina Redlup on June 9, 2010

H1n1

H1N1

Many provinces in Canada are beginning to report that their swine flu vaccination programs are failing.

Movement on for mandatory flu shots

by Ashton Daigle on June 9, 2010

Flu_vaccine

The movement for mandatory flu shots in medical facilities is beginning to catch on, according to a recent report by healthleadersmedia.com.

Molecular explanation for the evolution of Tamiflu resistance found

by Ashton Daigle on June 8, 2010

Tamiflu

Tamiflu

Caltech biologists have identified molecular changes that have assisted resistance in the antiviral drug Tamiflu, according to a statement released by Caltech officials.

Universal flu vaccine moves one step closer

by Daniel Purt on May 26, 2010

Flu_vaccine

Flu vaccine

A new influenza vaccine has been developed by researchers at Mount Sinai School of Medicine that brings a universal influenza vaccine one step closer and would eliminate the need for seasonal flu shots.

Vaccine body supports WHO action on pneumonia

by Ashton Daigle on May 20, 2010

Who

World Health Organization

The Global Alliance for Vaccines and Immunization hopes a resolution to increase efforts to combat pneumonia will be approved when they appear later this week before the World Health Organization, according to an Associated Press wire report.

Xcellerex announces successful production of swine flu H1 Hemagglutinin

by Ashton Daigle on May 19, 2010

1ru7_bio_r_500

H1 Hemagglutinin

Xcellerex officials announced this week that they have successfully produced swine flu H1 Hemagglutinin, California strain.

New findings could help develop vaccines for respiratory infections

by Ashton Daigle on May 12, 2010

Flu_vaccine

Influenza vaccine

Researchers at the Trudeau Institute reported in the current Journal of Experimental Medicine that they have identified two signaling components that could potentially allow for cellular immunity against the influenza virus and lead to vaccines against re

2 pandemic flu viruses’ lack of sugar could aid vaccine design

by Ted Purlain on March 30, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

The influenza viruses responsible for the pandemics of 1918 and 2009 share a structural detail that makes both susceptible to neutralization by the same antibodies, according to research by the NIAID.

Workers get flu shot if co-workers do, study says

by Tina Redlup on March 18, 2010

Flu_vaccine

IOWA CITY, Iowa — Increasing vaccination rates of health care personnel substantially improves patient safety, lowering flu deaths by 40 percent, researchers suggest.

Vaccinating children against flu helps everyone, study says

by Ted Purlain on March 16, 2010

Cdc

A new study shows that when children get vaccinated against seasonal influenza, the entire community can benefit.

Baxter presents results from Phase III study of Preflucel

by Tina Redlup on March 12, 2010

Flu_vaccine

DEERFIELD, Ill. — Baxter International Inc., in conjunction with DynPort Vaccine Co., announced Phase III study data measuring the clinical efficacy for its trivalent seasonal influenza candidate vaccine on March 11 in Miami.

W.Va. medical center recognized for mandatory flu vaccine program

by Rita Uplend on March 11, 2010

Flu_vaccine

Charleston Area Medical Center has been recognized by a state group for "going above and beyond the call of duty" in getting the flu vaccine to employees and preventing the potential spread of the disease, The Charleston Gazette reported March 11.

Novel strategies may vaccines’ increase stability, professor says

by Pat Dulnier on March 10, 2010

Fda-logo

Cell-based vaccines are at the forefront of influenza vaccine development, according to findings presented March 10 at the 14th International Congress on Infectious Diseases in Miami and reported by Pediatric SuperSite.

Advisory committee silent on high-dose flu vaccine for elderly

by Tina Redlup on March 4, 2010

Cdc

The U.S. Advisory Committee on Immunization Practices last week heard a report about the high-dose influenza vaccine that was recently approved for people 65 and older but voiced no preference for its use in that age group.

Egg allergy no bar to flu shot, researchers say

by Ted Purlain on March 3, 2010

Flu_vaccine

NEW ORLEANS — Most children with egg protein allergies who received influenza vaccinations had no adverse reactions, researchers said at the annual meeting of American Academy of Allergy, Asthma & Immunology, according to MedPage Today.

NasVax, Novartis sign vaccine research deal

by Daniel Purt on February 27, 2010

Vaccine

TEL AVIV — Israel's said Feb. 21 it had signed an agreement with Novartis to jointly investigate the feasibility of developing vaccines using its VaxiSome technology, including an improved flu vaccine, Reuters reported Feb. 21.

Dynavax selects clinical candidate in universal flu vaccine program

by Pat Dulnier on February 26, 2010

Fda-logo

BERKELEY, Calif. — Dynavax Technologies Corp. announced Feb. 25 that it has selected a clinical vaccine candidate for its novel Universal Flu program and completed key preclinical studies.

AltraVax acquires technology platform for vaccine development

by Paul Tinder on February 22, 2010

Hepb

Hepetitis B

AltraVax Inc. has acquired a vaccine development technology package that gives AltraVax an exclusive license to develop vaccines for infectious diseases and is targeting influenza, a treatment for hepatitis B and HIV.

Novavax reports positive data from its VLP vaccine study

by Pat Dulnier on February 10, 2010

Novavax-vlp-vaccine

Novavax's VLP Vaccine

Novavax Inc. announced Feb. 9 new data from a clinical study that began in May among healthy adults 18 to 49 years old with Novavax's trivalent seasonal influenza virus-like particle (VLP) vaccine.

Mandatory policy boosts vaccination rate among health care workers

by Rita Uplend on February 3, 2010

Vaccine

A mandatory influenza vaccination policy improves immunization rates among health care workers, according to a recent study of a large health care organization.

NanoBio Awarded Key Patent Covering Vaccine and Anti-Infective Product Platforms

by Pat Dulnier on February 3, 2010

Flu_vaccine

Flu Vaccine

NanoBio Corp. announced Feb. 2 that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company’s lead anti-infective and vaccine product candidates.

BARDA funding to support flu vaccine production in Vietnam

by Paul Tinder on January 28, 2010

Who

World Health Organization

PATH has received an award from the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services to support the enhancement of sustainable influenza vaccine production in Vietnam.

Novavax to present at Phacilitate's North American Vaccine Forum

by Ted Purlain on January 26, 2010

Phacilitate-2010

ROCKVILLE, Md.--Two officials from Novavax Inc. announced Jan. 25 that they will be presenting at Phacilitate's eighth annual Vaccine Forum Washington 2010.

Novartis flu adjuvant boosts wide protection, FDA study says

by Tina Redlup on January 22, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

WASHINGTON — A vaccine additive made by Novartis and used in its European influenza shots can boost the body's immune response to a wide range of viruses, U.S. researchers reported Jan. 20 according to Reuters.

FDA advisory committee to discuss 2010-11 flu vaccine

by Rita Uplend on January 20, 2010

Fda-logo

The FDA’s Vaccines and Related Biological Products Advisory Committee will meet Feb. 22 to discuss and make recommendations on the selection of strains to be included in the influenza virus vaccine for the 2010-11 season.

A case of novel H3N2 flu virus reported in Iowa, CDC says

by Paul Tinder on January 19, 2010

H3n2

H3N2

One case of human infection with a novel influenza A virus was reported by the Iowa Department of Public Health, according to FluView, a report from the Centers for Disease Control and Prevention for the week ending Jan. 9.

Flu vaccine’s effects reduced in arthritis patients treated with rituximab

by Tina Redlup on January 8, 2010

Flu_vaccine

Flu Vaccine

Flu shots do not protect arthritis patients who are being treated with the intravenous drug rituximab, according to a new study by Dutch researchers, The New York Times and Los Angeles Times reported Jan. 7.

CDC Flu Wrap

by Tina Redlup on January 2, 2010

Cdc

The Center for Disease Control has reported only four cases of flu-related pediatric mortality across seven states during the week ending January 2.

Trudeau Institute to receive $1.6 million more for vaccine program

by Paul Tinder on December 31, 2009

Flu_vaccine

Influenza Vaccine

SARANAC LAKE, N.Y. — The Trudeau Institute will receive an additional $1.6 million for its work with the U.S. Navy to research the impact and efficacy of combining influenza vaccinations with antiviral drugs.

CDC Flu Wrap

by Pat Dulnier on December 26, 2009

Cdc

The Center for Disease Control has reported only four cases of flu-related pediatric mortality across seven states during the week ending December 26.

FDA approves a high dose flu influenza vaccine intended for seniors

by Tina Redlup on December 24, 2009

Fda-logo

SILVER SPRING, Md. — The U.S. Food and Drug Administration approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

CDC Flu Wrap

by Rita Uplend on December 19, 2009

Cdc

The Center for Disease Control has reported only nine cases of flu-related pediatric mortality across seven states during the week ending December 19.

Crucell may add polio to protect vaccine sales, Reuters reports

by Paul Tinder on December 16, 2009

Who

World Health Organization

AMSTERDAM — Dutch biotech firm Crucell NV will likely look to add a sixth antigen to its portfolio of childhood vaccines as part of expected product add-ons after a stake sale to Johnson & Johnson, Reuters reported Dec. 15.

CDC Flu Wrap

by Tina Redlup on December 14, 2009

Cdc

The Centers for Disease Control has reported 16 flu-related deaths among children across nine states during the week ending December 5.

NanoBio says vaccine adjuvant also effective by injection

by Paul Tinder on December 7, 2009

Fda-logo

ANN ARBOR, Mich. — NanoBio Corp. announced Dec. 7 that its recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine elevated immune responses when administered via injections.

Universal flu vaccine trial a success, BiondVax Pharmaceuticals says

by Rita Uplend on December 7, 2009

Vaccine

Universal Flu Vaccine

RECHOVOT, Israel — BiondVax Pharmaceuticals Ltd. announced the success of the Phase I/II clinical trial of its Multimeric-001 universal flu vaccine on Dec. 7.

Medical countermeasure development should be priority, BARDA director says

by Tina Redlup on December 7, 2009

Flu_vaccine

Flu Vaccine

WASHINGTON — Congress, the Obama administration and taxpayers need to accept that drugmakers are not going to pursue discovery and development of emergency medical countermeasures out of the kindness of their hearts.

European agency advises of fever risk in children following Pandemrix vaccination

by Daniel Purt on December 5, 2009

Flu_vaccine

Pandemrix Vaccine

LONDON — The European Medicines Agency warned Dec. 4 that young children might experience fever after their second dose of the pandemic influenza vaccine Pandemrix.

CDC Flu Wrap

by Paul Tinder on November 30, 2009

Cdc

The Center for Disease Control has reported 35 flu-related pediatric deaths across 19 states during the week ending November 21, which brings the total to 301 cases so far in 2009. There were 90 in 2008, 77 in 2007, 43 in 2006 and 45 in 2005.

Novavax completes enrollment in study of seasonal flu vaccine in older adults

by Paul Tinder on November 30, 2009

Flu_vaccine

Flu Vaccine

ROCKVILLE, Md. — Novavax announced Nov. 30 that it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza virus-like particle vaccine candidate in healthy adults 60 years of age or older.

FDA approves Agriflu seasonal influenza vaccine

by Rita Uplend on November 30, 2009

Fda-logo

The U.S. Food and Drug Administration approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

Baxter hopes to build U.S. cell-based vaccine manufacturing plant

by Ted Purlain on November 28, 2009

Baxter-international

DEERFIELD, Ill. — Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines, the Chicago Tribune reported Nov. 26

CDC kicks off national travelers' health public awareness campaign

by Paul Tinder on November 24, 2009

Schuchat_anne

Anne Schuchat

Every holiday season, millions of Americans travel through the nation's airports, seaports, and train stations to spend time with loved ones.

Next-generation flu vaccine plant to open in North Carolina

by Rita Uplend on November 24, 2009

Flu_vaccine

Flu Vaccine

WASHINGTON -- Novartis will officially open the first next-generation flu vaccine plant in the United States on Nov. 24, but it will be years before it makes its first vaccine.

Panenza, Sanofi Pasteur’s H1N1 vaccine, approved in France

by Tina Redlup on November 18, 2009

H1n1

H1N1

LYON, France — Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced that the French drug agency Afssaps has granted marketing authorization in France for Panenza, its non-adjuvanted Influenza H1N1 2009 monovalent vaccine.

CDC Flu Wrap

by Pat Dulnier on November 16, 2009

Cdc

The Center for Disease Control has reported 21 flu-related deaths among children across 15 states during the week ending November 14. The numbers went down from the previous 35 cases in 17 states.

Novavax begins study comparing VLP vaccine with Fluzone

by Paul Tinder on November 13, 2009

Singhvi_rahul

Dr. Rahul Singhvi

ROCKVILLE, Md. — Novavax Inc. has begun a Phase IIa clinical study of its trivalent seasonal influenza VLP vaccine candidate in healthy adults over age 60.

CDC Flu Wrap

by Paul Tinder on November 13, 2009

Cdc

The Center for Disease Control has reported 18 flu-related deaths among children that occurred in nine states during the week ending October 31.

FDA approves GlaxoSmithKline’s pandemic H1N1 vaccine

by Pat Dulnier on November 12, 2009

Fda-logo

LONDON and PHILADELPHIA — GlaxoSmithKline announced Nov. 10 that the Food and Drug Administration has approved a supplemental biologics license application for its unadjuvanted H1N1 influenza vaccine.

Google teams up with U.S. agencies to pinpoint flu vaccine sites

by Rita Uplend on November 11, 2009

Google

Flu Finder

This year, it's especially important to have clear information on what you can do to prepare for the flu season.

Russia's health minister warns media against spreading flu panic

by Ted Purlain on November 10, 2009

Golikova_tatyana

Tatyana Golikova

MOSCOW — Russia's health minister warned the media against spreading panic over a swine and seasonal flu outbreak and said the situation was under control.

CDC Flu Wrap

by Tina Redlup on November 9, 2009

Cdc

The Center for Disease Control has reported 35 flu-related pediatric deaths that occurred in 17 states during the week ending November 9. The previous week only reported 18 deaths in nine states.

Novavax reports positive data for seasonal flu vaccine candidate

by Mary J. Lewis on November 4, 2009

Rahul_singhvi

Dr. Rahul Singhvi

ROCKVILLE, Md. — Novavax, Inc. announced Nov. 2 that its seasonal flu vaccine candidate met key goals in a midstage clinical trial.

IDSA strengthens mandatory immunization policy

by Ted Purlain on October 31, 2009

Dr

Dr. Anne Gershon

To better protect patients and health care workers, the Infectious Diseases Society of America recently strengthened its policy on mandatory immunization of workers. The strengthened statement applies to both seasonal influenza and 2009 H1N1 influenza.

Vaccinated moms less likely to have small or premature babies

by Mary J. Lewis on October 31, 2009

William_schaffner

Dr. William Schaffner

PHILADELPHIA — Pregnant women who get the flu vaccine are less likely to have babies who are premature or are small for their gestational age, according to two new studies.

Flu vaccine given during pregnancy keeps infants out of hospital

by Mary J. Lewis on October 29, 2009

Marietta_vázquez

Marietta Vázquez

NEW HAVEN, Conn. — Infants born to women who received influenza vaccine during pregnancy were hospitalized at a lower rate than infants born to unvaccinated mothers, according to preliminary results of an ongoing study.

First family takes flu shots; daughters take H1N1 vaccine too

by Rita Uplend on October 29, 2009

Obama-family

First Family

WASHINGTON — Yes, President Barack Obama and his family have had their shots. According to the White House, all four members of the Obama family have received their seasonal flu vaccine.

FDA OKs seasonal influenza vaccine Fluarix for pediatric use

by Mary J. Lewis on October 12, 2009

Fluarix_cropped

The U.S. Food and Drug Administration approved use of the seasonal influenza vaccine Fluarix for children ages 3 to 17.